Scientists deconstruct the protein-based machine responsible for SARS-CoV-2 replication
In February 2020, a trio of bio-imaging experts were sitting amiably around a dinner table at a scientific conference in Washington, D.C., when the conversation shifted to what was then a worrying viral epidemic in China. Without foreseeing the global disaster to come, they wondered aloud how they might contribute.
Nearly a year and a half later, those three scientists and their many collaborators across three national laboratories have published a comprehensive study in Biophysical Journal that - alongside other recent, complementary studies of coronavirus proteins and genetics - represents the first step toward developing treatments for that viral infection, now seared into the global consciousness as COVID-19.
Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2
sciencemag.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemag.org Daily Mail and Mail on Sunday newspapers.
Deconstructing the infectious machinery of SARS-CoV-2
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Deconstructing the Infectious Machinery of the SARS-CoV-2 Virus
lbl.gov - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lbl.gov Daily Mail and Mail on Sunday newspapers.